-Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients after 2-Years of Open-Label Maintenance

Media coverage

• Title	-Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients after 2-Years of Open-Label Maintenance
  Media name/outlet	M2 PressWIRE
  Country/Territory	United States
  Date	4/10/24
  Persons	Marla Dubinsky

• Title	-Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients after 2-Years of Open-Label Maintenance
  Media name/outlet	ENP Newswire
  Country/Territory	United Kingdom
  Date	4/10/24
  Persons	Marla Dubinsky